Publications
Associations between salivary, protein-unbound and total plasma concentrations of rifampicin
Charles M. Mtabho* Hadija H. Semvua*, Marga Teulen, Angela Colbers, Rogate Machange, Arnold Ndaro, André van der Ven, David Burger, Gibson S. Kibiki, Rob E. Aarnoutse
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
Migliori, G. B. 1 ; Marx, F. M. 2 ; Ambrosino, N. 3 ; Zampogna, E. 4 ; Schaaf, H. S. 5 ; van der Zalm, M. M. 5 ; Allwood, B. 6 ; Byrne, A. L. 7 ; Mortimer, K. 8 ; Wallis, R. S. 9 ; Fox...
Pharmacokinetics of rifampicin, pyrazinamide and ethambutol in Tanzanian tuberculosis patients
Alma Tostmann12, Charles M. Mtabho3, Jossy van den Boogaard2 3, Hadija H. Semvua3, Constantine F. Irongo", Gibson S. Kibiki3, Martin J. Boeree 1 2, Rob E. Aarnoutse 5
Patrick L. Mabula* a,e, Kelly I. Kazinyingi a, Edwin Christian Chavala a, Victor Mosha b, Sia E. Msuya b,c,d , Beatrice John Leyaro c
Elizabeth F Msoka1, Fred Orina2, http://orcid.org/0000-0002-1764-545XErica Samson...
Quality Surveillance of Anti-Tuberculosis Medicines in Tanzania, 2012-2018
Kissa W. Mwamwitwa1*, Betty A. Maganda2, Seth Kisenge1, Sophia A. Mziray1, Henry Irunde1, Yonah H. Mwalwisi1, Adam M. Fimbo1, Wilbroad Kalala2, Adelard Mtenga1, Akida M. Khea1, Adonis Bitegeko1, Danstan H...
Mayanda, A.1, Kaaya, R. 2, Sylvester, B.3 and Kavishe, R4
The burden and determinants of post-TB lung disease
S. G. Mpagama,1,2 K. S. Msaji,1 O. Kaswaga,1 L. J. Zurba,3 P. M. Mbelele,1,4 B. W. Allwood,5 B-S. Ngungwa,1 R. M. Kisonga,1 M. Lesosky,6 J. Rylance,7,8 K. Mortimer;8 on behalf of the lung health in Africa across the life course collaboration*
Tuberculosis preventive therapy for people with diabetes mellitus
Willyhelmina Olomi 1, Irene Andia Biraro 2 3, Kajiru Kilonzo 4, Lindsey Te Brake 5, Davis Kibirige 2 6, Nyasatu Chamba 7, Nyanda Elias Ntinginya 1, Issa Sabi 1, Julia Critchley 8, Katrina Sharples 9, Philip C Hill 9, Reinout Van Crevel 5...